Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,995.00    -17.00 (-0.84%)
Bid:
1,979.00
Ask:
1,984.00
Spread: 5.00 (0.253%)
Market Cap: £3.34b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

JM restated HY numbers for new reporting structure

1 Aug 2022 07:00

RNS Number : 3338U
Johnson Matthey PLC
01 August 2022
 

News release

1 August 2022, 07:00 BST

 

 

Restated half year numbers for new reporting structure

As announced in our preliminary full year results in May, we have changed our reporting structure for the year ending 31st March 2023.

Today, we provide restated numbers by business - now also including the half year detail - for the years ending 31st March 2021 and 31st March 2022. Please see the appendix on page 2.

 

ENDS

 

Enquiries: 

Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

+44 20 7269 8241

+44 20 7269 8235

+44 20 7269 8004

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774

Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

Appendix

 

Sales

(£ million)

2021/22

 

2020/21

1H

2H

FY

 

1H

2H

FY

Clean Air

1,196

1,261

2,457

1,003

1,409

2,412

PGM Services

300

287

587

215

316

531

Catalyst Technologies

223

231

454

196

247

443

Hydrogen Technologies

10

15

25

19

22

41

Value Businesses¹,²

181

173

354

172

199

371

Eliminations

(55)

(44)

(99)

(45)

(68)

(113)

Total sales

1,855

1,923

3,778

 

1,560

2,125

3,685

Health (discontinued)

83

79

162

 

119

118

237

Total sales (as reported)

1,938

2,002

3,940

 

1,679

2,243

3,922

 

Operating profit

(£ million)

2021/22

 

2020/21

1H

2H

FY

 

1H

2H

FY

Clean Air

150

152

302

77

192

269

PGM Services

167

141

308

78

166

244

Catalyst Technologies

30

20

50

10

22

32

Hydrogen Technologies

(12)

(21)

(33)

-

1

1

Value Businesses¹,³

1

11

12

(2)

2

-

Corporate

(39)

(47)

(86)

(27)

(46)

(73)

Total operating profit

297

256

553

 

136

337

473

Health (discontinued)

(4)

7

3

 

15

16

31

Total operating profit (as reported)

293

263

556

 

151

353

504

 

Notes:

1.

Value Businesses includes Battery Systems, Medical Device Components, Diagnostic Services, Battery Materials (completion expected summer 2022), Advanced Glass Technologies (divestment completed February 2022), Water and Atmosphere Control Technologies (divestments completed November 2020).

2.

Sales relating to divestments:

·

2021/22 includes Advanced Glass Technologies (1H: £37m, 2H: £25m) and Battery Materials (1H: £6m, 2H: £6m).

·

2020/21 includes Advanced Glass Technologies (1H: £27m, 2H: £39m), Battery Materials (1H: £6m, 2H: £8m) and Other - Water and Atmosphere Control Technologies (1H: £13m, 2H: £4m).

3.

Operating profit relating to divestments:

·

2021/22 includes Advanced Glass Technologies (1H: £10m, 2H: £6m) and Battery Materials (1H: -£17m, 2H: -£5m).

·

2020/21 includes Advanced Glass Technologies (1H: £5m, 2H: £12m), Battery Materials (1H: -£10m, 2H: -£13m) and Other - Water and Atmosphere Control Technologies (1H: £1m, 2H: £nil).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STREAKXNAFNAEFA
Date   Source Headline
10th Jun 202610:00 amRNSAnnual Financial Report
3rd Jun 20269:03 amRNSDirector/PDMR Shareholding
2nd Jun 20264:40 pmRNSDirector/PDMR Shareholding
1st Jun 20264:02 pmRNSHolding(s) in Company
28th May 20267:05 amRNSBoard Changes
28th May 20267:01 amRNSJohnson Matthey acquisition of Cormetech
28th May 20267:00 amRNSJohnson Matthey Full Year Results
14th May 202611:42 amRNSDirector/PDMR Shareholding
16th Apr 202611:51 amRNSDirector/PDMR Shareholding
24th Mar 202611:30 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSDirector Declaration
24th Feb 20263:30 pmRNSDirector/PDMR Shareholding
24th Feb 20269:48 amRNSDirector/PDMR Shareholding
23rd Feb 20265:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20267:00 amRNSUpdate on Catalyst Technologies sale
12th Feb 202612:44 pmRNSDirector/PDMR Shareholding
14th Jan 20262:22 pmRNSDirector/PDMR Shareholding
8th Jan 202610:01 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20254:51 pmRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSDirectorate change
20th Nov 20257:00 amRNSJohnson Matthey Half Year Results
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
24th Oct 202511:29 amRNSHolding(s) in Company
21st Oct 20253:44 pmRNSHolding(s) in Company
13th Oct 202511:55 amRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSFinancial reporting structure and trading update
3rd Oct 202510:23 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSHolding(s) in Company
26th Sep 20255:29 pmRNSHolding(s) in Company
17th Sep 20259:00 amRNSDirector Declaration
15th Sep 20252:37 pmRNSHolding(s) in Company
11th Sep 20254:13 pmRNSDirector/PDMR Shareholding
8th Sep 20256:00 pmRNSHolding(s) in Company
4th Sep 20255:19 pmRNSHolding(s) in Company
2nd Sep 20254:07 pmRNSHolding(s) in Company
29th Aug 202512:05 pmRNSTotal Voting Rights
26th Aug 20252:07 pmRNSDirector/PDMR Shareholding
13th Aug 20254:38 pmRNSDirector/PDMR Shareholding
13th Aug 20251:51 pmRNSDirector/PDMR Shareholding
5th Aug 20255:19 pmRNSHolding(s) in Company
5th Aug 20254:50 pmRNSDirector/PDMR Shareholding
25th Jul 20252:12 pmRNSHolding(s) in Company
23rd Jul 20252:23 pmRNSHolding(s) in Company
18th Jul 202512:07 pmRNSDirector/PDMR Shareholding
18th Jul 20259:18 amRNSHolding(s) in Company
17th Jul 20252:20 pmRNSResult of AGM
17th Jul 20257:00 amRNSAppointment of Andrew Cosslett as Chair

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.